AUPH
Aurinia Pharmaceuticals (AUPH) Investor Questions
Review Aurinia Pharmaceuticals (AUPH) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Aurinia Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 73
- Annual revenue
- $283.06M
- Annual net income
- $287.20M
- Annual free cash flow
- $135.41M
Aurinia Pharmaceuticals (AUPH) Investor Questions research
Aurinia Pharmaceuticals trades under the ticker AUPH. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review AUPH through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.